{"id":511303,"date":"2021-07-09T07:33:08","date_gmt":"2021-07-09T11:33:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/"},"modified":"2021-07-09T07:33:08","modified_gmt":"2021-07-09T11:33:08","slug":"tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/","title":{"rendered":"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference"},"content":{"rendered":"<h2>\nFireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>NEW YORK, July  09, 2021  (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will participate in a fireside chat during the Ladenburg Thalmann 2021 Healthcare Conference being held virtually. The fireside chat is scheduled to take place on Wednesday, July 14, 2021 at 12:30 PM ET.<\/p>\n<p>A live webcast of each presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OBpa9AwbOWUY2dhU7NIvpUsnllhXKesGF8Uq0JkNSqkfz_pkxmsZ0Sc9wrm16UP2VHizDXyUmFLVDVwI1SnCD08rQTP3c4HrO0f1MuZWw7goG5BolHO6Yq1hUW1uGM_o\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.tgtherapeutics.com\/events<\/a>. Following each event, an archive file will be available for thirty days.<\/p>\n<p>\n        <strong>ABOUT TG THERAPEUTICS, INC.<\/strong><br \/>\n        <br \/>TG Therapeutics\u00a0is a fully-integrated, commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. In addition to an active research pipeline including five investigational medicines across these therapeutic areas, TG has received accelerated approval from the\u00a0U.S.\u00a0FDA for UKONIQ\u2122\u00a0(umbralisib), for the treatment of adult patients with relapsed\/refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed\/refractory follicular lymphoma who have received at least three prior lines of systemic therapies. Currently, the Company has three programs in Phase 3 development for the treatment of patients with relapsing forms of multiple sclerosis (RMS) and patients with chronic lymphocytic leukemia (CLL) and several investigational medicines in Phase 1 clinical development.\u00a0For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CSXGBlA-Pn_c5VQFPJTMlAXoan8cYbqSJlQyGKSIbwxGlHcPgv0lbkKx2G-5_NHn4ayx-XKmagHaomgiqsDgUPyLGr6r1icNu41mE_Uk6zs=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.tgtherapeutics.com<\/u><\/a>, and follow us on Twitter\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mo6jRAPcumSbpO2SRe6OermnA_p4SjOVmJmUNyX5BRPNjCFOtRur-PXVgY0UiGIn7dVQGQx3KsVSkpax8h_GrZFnM51YzO7-Zfe8zf4v2Es=\" rel=\"nofollow noopener\" target=\"_blank\"><u>@TGTherapeutics<\/u><\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SEI3aEBYptRiCrn4nwJ3UQrx2tRJUSJUNLtCNpBAE3LVjsOx7Yi0gH5JkWBmP125ITW8S9swQwj7gtRyk29JAnkzVeC63w_PmvDeAf1uevA=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Linkedin<\/u><\/a>.<\/p>\n<p>UKONIQ\u2122 is a trademark of\u00a0TG Therapeutics, Inc.<\/p>\n<p>CONTACT:<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i30bYsqqCcipkdhfyBNFRpuiuRyxQ87RRm3jiSnlZg69c8UBzs0MsUS1RX4oGtuB_DKPMgCVnahm_tlybENgiA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>ir@tgtxinc.com<\/u><\/a><br \/>Telephone: 1.877.575.TGTX (8489), Option 4<\/p>\n<p>\n        <strong>Media Relations: <\/strong><br \/>\n        <br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=J2Wg5kSukPWnfOJoTygaHtmOmUY7a2WdQTYazlazuL1jw8jjQ_-zb_5NiftBMr7Yr3Uuw1QRXckHkRMXi7lX7Q==\" rel=\"nofollow noopener\" target=\"_blank\"><u>media@tgtxinc.com<\/u><\/a><br \/>Telephone: 1.877.575.TGTX (8489), Option 6<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/86c45a44-339c-4bb9-971c-8d586488de6e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET NEW YORK, July 09, 2021 (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will participate in a fireside chat during the Ladenburg Thalmann 2021 Healthcare Conference being held virtually. The fireside chat is scheduled to take place on Wednesday, July 14, 2021 at 12:30 PM ET. A live webcast of each presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at https:\/\/ir.tgtherapeutics.com\/events. Following each event, an archive file will be available for thirty days. ABOUT TG THERAPEUTICS, INC. TG Therapeutics\u00a0is a fully-integrated, commercial stage biopharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511303","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Fireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET NEW YORK, July 09, 2021 (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will participate in a fireside chat during the Ladenburg Thalmann 2021 Healthcare Conference being held virtually. The fireside chat is scheduled to take place on Wednesday, July 14, 2021 at 12:30 PM ET. A live webcast of each presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at https:\/\/ir.tgtherapeutics.com\/events. Following each event, an archive file will be available for thirty days. ABOUT TG THERAPEUTICS, INC. TG Therapeutics\u00a0is a fully-integrated, commercial stage biopharmaceutical &hellip; Continue reading &quot;TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-09T11:33:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference\",\"datePublished\":\"2021-07-09T11:33:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/\",\"name\":\"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=\",\"datePublished\":\"2021-07-09T11:33:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk","og_description":"Fireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET NEW YORK, July 09, 2021 (GLOBE NEWSWIRE) &#8212; TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company\u2019s Chairman and Chief Executive Officer, will participate in a fireside chat during the Ladenburg Thalmann 2021 Healthcare Conference being held virtually. The fireside chat is scheduled to take place on Wednesday, July 14, 2021 at 12:30 PM ET. A live webcast of each presentation will be available on the Events page, located within the Investors &amp; Media section, of the Company\u2019s website at https:\/\/ir.tgtherapeutics.com\/events. Following each event, an archive file will be available for thirty days. ABOUT TG THERAPEUTICS, INC. TG Therapeutics\u00a0is a fully-integrated, commercial stage biopharmaceutical &hellip; Continue reading \"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-09T11:33:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference","datePublished":"2021-07-09T11:33:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/","name":"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=","datePublished":"2021-07-09T11:33:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzcxMCM0Mjg5NTY3IzIwMjA3OTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511303"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511303\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}